Yuflyma News - Latest Updates & Headlines
Celltrion gets interchangeability approval for biosimilar of Humira in US
Seoul, April 14: Celltrion, a major South Korean biopharmaceutical firm, on Monday said it has obtained an interchangeability approval for its biosimilar drug for autoimmune disease treatment in the United States.